Is Wegovy and Ozempic the Same? UK Comparison | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy vs Ozempic UK - Compare Prices

Get Wegovy at the cheapest UK price from £69.00 — Save £20 with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £69.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Is Wegovy and Ozempic the Same Medication in the UK?

Many patients ask: is Wegovy and Ozempic the same? While both contain the active ingredient semaglutide, they are licensed for different purposes in the UK — Wegovy is specifically approved for chronic weight management, whereas Ozempic is licensed only for type 2 diabetes treatment. Understanding these critical differences helps ensure you receive the correct prescription medication for your clinical needs, under the supervision of a UK-registered prescriber.

Is Wegovy and Ozempic the Same Active Ingredient?

Yes, both Wegovy and Ozempic contain semaglutide, a GLP-1 receptor agonist that mimics a naturally occurring hormone to regulate appetite and blood sugar[1]. Semaglutide works by slowing gastric emptying, enhancing insulin secretion, and reducing glucagon release, which together contribute to improved glycaemic control and reduced caloric intake.

Despite sharing the same active pharmaceutical ingredient, the two products differ significantly in their licensed indications, maximum doses, and prescribing criteria in the UK. Ozempic is approved by the MHRA exclusively for managing type 2 diabetes mellitus, with doses up to 1 mg weekly (or 2 mg in some cases)[2]. Wegovy, by contrast, is licensed specifically for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities, and is titrated up to a maintenance dose of 2.4 mg weekly[3].

Prescribing Ozempic off-label for weight loss is not supported by UK regulatory guidance and may not be covered by standard clinical protocols. Patients seeking semaglutide for weight management should request Wegovy through a legitimate online assessment with a UK-registered prescriber, ensuring compliance with MHRA and NICE recommendations.

Key Differences: Is Wegovy and Ozempic the Same Dose and Strength?

A common misconception is that Wegovy and Ozempic are interchangeable simply because they contain semaglutide. In reality, the dosing schedules and maximum strengths differ substantially. Ozempic pens deliver doses of 0.25 mg, 0.5 mg, 1 mg, or 2 mg, designed to optimise glucose control in diabetic patients[2]. Wegovy, however, follows a structured escalation protocol starting at 0.25 mg and increasing every four weeks to reach the therapeutic dose of 2.4 mg weekly, which has been shown in the STEP clinical trial programme to produce an average weight reduction of approximately 15% of baseline body weight over 68 weeks[3].

This higher maintenance dose is central to Wegovy's efficacy for weight loss and is not typically prescribed under Ozempic's diabetes indication. Using Ozempic at sub-therapeutic doses for weight management may result in suboptimal outcomes and does not align with the evidence base supporting semaglutide 2.4 mg for obesity treatment.

Patients should be aware that only Wegovy is formulated and licensed to deliver the 2.4 mg dose required for clinically significant weight loss. Attempting to achieve equivalent results with Ozempic is both off-label and unsupported by UK prescribing standards.

Wegovy Dosing Schedule for Weight Loss

Wegovy's titration schedule is designed to minimise gastrointestinal side effects while gradually reaching the target dose. The protocol begins with 0.25 mg weekly for four weeks, then 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg weekly[3]. This stepwise approach allows the body to adapt to increasing semaglutide exposure, reducing the incidence of nausea, vomiting, and diarrhoea commonly reported during initiation.

Adherence to this schedule is critical for both tolerability and efficacy. Patients who skip dose escalations or attempt to start at higher doses without medical supervision risk significant adverse effects and may discontinue treatment prematurely.

Is Wegovy and Ozempic the Same Price in the UK?

Pricing varies between the two products due to differences in licensing, supply chains, and demand. At Cured Pharmacy, Wegovy is available from £69.00 per pen, representing competitive UK pricing for a weight-loss-licensed semaglutide product[4]. Ozempic, being indicated for diabetes, is often available on NHS prescription for eligible diabetic patients, but private supply for off-label weight loss is neither recommended nor supported by our clinical team.

Patients seeking the most cost-effective and clinically appropriate option for weight management should choose Wegovy, which is specifically designed and dosed for this indication. Using Ozempic off-label may appear cheaper initially, but without the correct titration and dose, it is unlikely to deliver the weight loss outcomes demonstrated in robust clinical trials.

Cured Pharmacy offers transparent upfront pricing and a free online consultation with a UK-registered prescriber to assess suitability for Wegovy. New patients can Save £20 on their first order using code Weightlossnew, ensuring access to genuine, MHRA-approved medication at the cheapest UK price.

Feature Wegovy Ozempic
Active Ingredient Semaglutide Semaglutide
Licensed Indication Weight management Type 2 diabetes
Maximum Dose 2.4 mg weekly 1 mg (or 2 mg) weekly
Starting Price (Cured) From £89.00 Not offered for weight loss
MHRA Approval for Weight Loss Yes No
NICE Recommended for Obesity Yes No
Typical Weight Loss (68 weeks) ~15% body weight ~5-10% (diabetes trials)

Clinical Evidence: Is Wegovy and Ozempic the Same for Weight Loss?

The evidence base for semaglutide in weight management comes primarily from the STEP trial programme, which evaluated semaglutide 2.4 mg (Wegovy) in over 4,500 participants without diabetes[3]. Results showed an average weight loss of 14.9% from baseline at 68 weeks, compared to 2.4% with placebo, alongside improvements in cardiometabolic risk factors including waist circumference, blood pressure, and lipid profiles.

Ozempic's pivotal trials (SUSTAIN programme) focused on glycaemic control in type 2 diabetes, with weight loss observed as a secondary outcome at lower doses (up to 1 mg weekly)[2]. While patients did experience modest weight reduction, the magnitude was significantly less than that achieved with Wegovy's 2.4 mg dose, and the study populations differed in baseline characteristics and primary endpoints.

Attempting to extrapolate Ozempic's diabetes data to weight management is scientifically unsound. Wegovy is the only semaglutide formulation with a robust evidence base specifically supporting its use for chronic weight management in non-diabetic populations, and it remains the appropriate choice for patients seeking clinically meaningful, sustained weight loss.

Safety and Tolerability: Is Wegovy and Ozempic the Same Side Effect Profile?

Both medications share a common side effect profile typical of GLP-1 receptor agonists, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort[1][3]. These effects are generally dose-dependent and tend to diminish over time with continued use and gradual dose escalation.

However, because Wegovy reaches a higher maintenance dose (2.4 mg), some patients may experience more pronounced gastrointestinal symptoms compared to those on lower-dose Ozempic regimens. Proper titration, dietary modification, and close monitoring by a healthcare professional can mitigate these effects. Serious adverse events such as pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in rodent studies) are rare but require clinical vigilance across both products.

Regulatory Status: Is Wegovy and Ozempic the Same in UK Licensing?

In the UK, Wegovy and Ozempic hold distinct marketing authorisations from the MHRA. Ozempic is licensed solely for improving glycaemic control in adults with type 2 diabetes mellitus, either as monotherapy or in combination with other glucose-lowering agents[2]. It is not approved for weight management, and prescribing it for this purpose constitutes off-label use, which carries legal and clinical implications for both prescriber and patient.

Wegovy received its UK marketing authorisation specifically for weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity, such as hypertension, dyslipidaemia, or obstructive sleep apnoea[3]. This distinction is not merely administrative — it reflects differences in the clinical trial data submitted for regulatory approval and the populations in which safety and efficacy have been established.

NICE guidance supports the use of semaglutide 2.4 mg (Wegovy) within specialist weight management services, subject to specific eligibility criteria and ongoing monitoring. Patients should ensure their prescription aligns with these recommendations and is issued following a comprehensive clinical assessment by a UK-registered prescriber, as provided through Cured Pharmacy's online consultation service.

How to Get Wegovy Online: Is Wegovy and Ozempic the Same Prescription Process?

While both medications require a prescription from a UK-registered healthcare professional, the assessment process differs based on the indication. Requesting Ozempic for weight loss is inappropriate and will not be supported by responsible prescribers. Wegovy, however, can be prescribed following a thorough online consultation that evaluates your BMI, medical history, current medications, and weight-related comorbidities.

At Cured Pharmacy, our clinical team — led by superintendent pharmacist Tarun Kumar (GPhC 2233073) — conducts a comprehensive assessment in under three minutes to determine suitability for Wegovy. This process ensures compliance with MHRA regulations and NICE guidelines, safeguarding patient safety while providing convenient access to genuine, UK-licensed medication.

Once approved, Wegovy is dispensed discreetly and delivered via next-day courier, with full patient information leaflets and ongoing support from our registered pharmacists. New patients benefit from £20 off their first order using code Weightlossnew, making Wegovy accessible at the cheapest UK price without compromising clinical standards or product authenticity.

Why Choose Cured Pharmacy for Wegovy?

Cured Pharmacy is a fully registered UK online pharmacy (GPhC 9012511), committed to transparent pricing, genuine medications, and expert clinical care. Unlike unregulated suppliers or those offering off-label Ozempic for weight loss, we provide only MHRA-approved treatments prescribed in accordance with current UK guidelines.

Our service includes free online consultations, discreet packaging, and the lowest prices guaranteed in the UK. Every prescription is reviewed by a qualified prescriber, ensuring you receive the right medication at the right dose for your individual needs. For patients seeking safe, effective, and legally compliant access to semaglutide for weight loss, Wegovy from Cured Pharmacy is the clear choice.

Scientific References

  1. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 15 August 2026]
  2. Marso, S. P., Bain, S. C., Consoli, A., et al. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834-1844. [accessed 15 August 2026]
  3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  4. Cured Pharmacy. (2025). Wegovy (Semaglutide) Weight Loss Injection. Retrieved from https://curedpharmacy.com/products/wegovy-semaglutide-weight-loss-injection [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Wegovy and Ozempic the same medication?
Both contain semaglutide, but Wegovy is licensed for weight management at 2.4 mg weekly, while Ozempic is approved only for type 2 diabetes at lower doses.
Can I use Ozempic instead of Wegovy for weight loss?
No, Ozempic is not licensed for weight loss in the UK, and prescribing it off-label for this purpose is not supported by MHRA or NICE guidance.
Is Wegovy and Ozempic the same price?
Pricing differs due to licensing and indication. Wegovy is available from £69.00 at Cured Pharmacy, while Ozempic for weight loss is not offered by responsible UK pharmacies.
What dose of semaglutide is used for weight loss?
Wegovy delivers 2.4 mg weekly at maintenance, the dose proven in STEP trials to achieve clinically significant weight loss.
Is Wegovy and Ozempic the same for side effects?
Both share similar gastrointestinal side effects, but Wegovy's higher dose may cause more pronounced symptoms during titration.
Do I need a prescription for Wegovy in the UK?
Yes, Wegovy requires a prescription from a UK-registered prescriber following a clinical assessment, available online at Cured Pharmacy.
How quickly does Wegovy work compared to Ozempic?
Wegovy's titration to 2.4 mg takes approximately 16-20 weeks, with progressive weight loss observed throughout the escalation period.
Can I switch from Ozempic to Wegovy?
Yes, under prescriber guidance. Patients on Ozempic for diabetes may transition to Wegovy if weight management becomes a clinical priority, subject to assessment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.